SecBot SecBot
Institutional Cluster

TRVI

Trevi Therapeutics, Inc.
MIXED
Impact 4/10
Horizonweeks Processed5mo ago
Institutional cluster: 8 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The cluster is dominated by passive/index managers and likely reflects index rebalancing or broad sector rotation into small-cap biotech, not a company-specific catalyst. With Wellington's massive DOUBLED position (+1792% to $29.8M) as the sole active manager signal, watch for next earnings and pipeline updates to see if conviction follows.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$13.46
T+0 close · Jun 11, 2026 · via day close
Latest settled
+28.23%
T+60 · $17.26
Vs SPY
+23.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $13.46entry
  2. T+1 · 5mo ago +5.57%α +5.03% · $14.21
  3. T+5 · 5mo ago +21.62%α +21.19% · $16.37
  4. T+20 · 4mo ago +36.70%α +34.81% · $18.40
  5. T+60 · 2mo ago +28.23%α +23.84% · $17.26

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A strong institutional cluster for Trevi Therapeutics (TRVI) in Q3 2025 shows 8 buyers adding $111.4M in aggregate holdings vs. 5 sellers trimming $5.4M, a heavily lopsided net accumulation. The buying is dominated by passive/index funds (Fidelity, Morgan Stanley, Schwab, Wells Fargo, Invesco, BofA) and two asset managers (Wellington, Legal & General), while the selling comes from quant and asset managers (Citadel, RenTech, Point72, Dimensional, Barclays). The magnitude of net buying ($111.4M) relative to a $1.9B market cap is notable (~5.9% of cap), but the active vs. passive split and lack of disclosed catalysts suggest the move was driven primarily by index-related flows and passive rebalancing into a rising biotech stock, not a concentrated active thesis.

Key Financial Metrics

Direction
accumulating
Buy Value
$129.2M
Sell Value
$5.4M
Net Flow
$106.0M

Institutional Positions

Net institutional flow: $106.0M

▲ Buyers (8)

InstitutionActionChangePosition ValueValue Δ
FidelityDOUBLED+795.4%$30.2M$28.2M
Morgan StanleyDOUBLED+320.1%$39.4M$33.8M
Wellington Management GroupDOUBLED+1792%$29.8M$28.8M
BofAADD+67.4%$16.8M$10.8M
SchwabDOUBLED+256.9%$7.4M$6.1M

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
CitadelNEAR_EXIT-92.2%$7.2M-$6.3M
Point72TRIM-45.5%$9.5M-$837.2K
RenTechTRIM-40.1%$2.7M$7.0K
Dimensional Fund AdvisorsTRIM-67.3%$695.0K-$315.8K
BarclaysTRIM-57.9%$3.0K$2.0M

Key Facts

  • 8 institutions accumulated $129.2M in aggregate TRVI holdings, adding $111.4M in net new value during Q3 2025
  • 5 institutions reduced holdings by $5.4M, with Citadel (NEAR_EXIT, -92.2%) leading the sell-side
  • 6 of 8 buyers are mega-passive/index-tracking managers (Fidelity, Morgan Stanley, Schwab, Invesco, BofA, Wells Fargo), the signal is dominated by passive rebalancing
  • Two active asset managers, Wellington (DOUBLED, +1792% to $29.8M) and Legal & General (DOUBLED, +870% to $750K), also added meaningfully
  • The cluster data is from 2025-Q3 (ended Sep 30) and subject to the 45-day 13F filing lag, current positions may differ

Financial Impact

8 buyers added $111.4M in new net value (total holdings $129.2M) while 5 sellers reduced by $5.4M, net institutional accumulation of ~$106M in Q3 2025

institutional_ownership_accumulationpassive_vs_active_flow_split

Risk Factors

  • 13F data is retrospective (quarter-end Sep 30, filed by Nov 14); passive inflows may have already been unwound or reversed in Q4
  • The sell-side includes Citadel and Point72, quant selling may indicate alpha decay or hedging that counters the passive buying thesis
  • No specific catalyst (pipeline milestone, approval, partnership) is evident from the cluster data alone to justify forward price appreciation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-TRVI-2025-Q3

Track record

12 reports on TRVI

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +15.38% at T+60 after the Mar 9, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $14.91 settles Dec 9
  2. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $13.52 settles Nov 25
  3. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $13.46 to $18.40 ▲ +36.70% +34.81% vs SPY
  4. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Viewing Entry $13.46 to $18.40 ▲ +36.70% +34.81% vs SPY
  5. Apr 21, 202629w ago DEFA14A Neutral 3/10 Entry $14.80 to $13.24 ▼ −10.54% −13.71% vs SPY
  6. Apr 20, 202630w ago Press Release Neutral 5/10 Entry $14.62 to $13.43 ▼ −8.14% −13.05% vs SPY
  7. Apr 17, 202630w ago 424B5 Bearish 7/10 Entry $15.40 to $13.43 ▲ +12.79% +16.99% vs SPY
  8. Apr 17, 202630w ago 8-K Bearish 7/10 Entry $15.23 to $15.08 ▲ +0.98% +6.36% vs SPY
  9. Apr 16, 202630w ago Press Release Neutral 6/10 Entry $15.23 to $15.08 ▼ −0.98% −6.36% vs SPY
  10. Mar 17, 202634w ago Press Release Mixed 6/10 Entry $10.69 to $14.54 ▲ +36.02% +29.97% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026